Marksans Pharma has informed that it enclosed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2023 received from Bigshare Services, Registrar and Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.